TL;DR
This study investigates the antiaging potential of peptides derived from Chinese pond turtle (CPTP). CPTP demonstrated significant antioxidant activity and extended lifespan in Drosophila melanogaster, primarily by activating the Nrf2/Keap1 signaling pathway. The research also identified specific CPTP sequences that interact with Keap1, suggesting a mechanism for its antiaging effects.
What Problem Does This Paper Address?
Aging is a complex biological process characterized by cellular damage and functional decline, with oxidative stress being a major contributing factor. While the Nrf2/Keap1 signaling pathway is a known regulator of antioxidant defense and is implicated in aging, there's a continuous need for novel, safe, and effective bioactive compounds that can modulate this pathway to combat age-related decline. Traditional remedies, like Chinese pond turtle, are often anecdotally linked to longevity, but scientific validation and mechanistic understanding are frequently lacking. This paper aims to bridge this gap by exploring the antiaging and antioxidant properties of Chinese pond turtle peptides (CPTP) and elucidating their underlying molecular mechanisms, specifically focusing on the Nrf2/Keap1 pathway.
Methods
The study employed a multi-faceted approach:
- In vitro antioxidant assays: Standard assays like DPPH, ABTS, and hydroxyl radical scavenging, along with a reducing power assay, were used to quantify the antioxidant capacity of CPTP.
- Drosophila melanogaster model: This model organism was chosen for its short lifespan, ease of genetic manipulation, and conserved aging pathways.
- Lifespan analysis: Flies were fed a diet supplemented with CPTP to assess its impact on mean, median, and maximum lifespan.
- Stress resistance assays: Flies were subjected to oxidative (H2O2), heat, and starvation stress to evaluate CPTP's protective effects.
- Feeding assay: To rule out lifespan extension being due to reduced food intake, a feeding assay was conducted.
- Biochemical index determination: Levels of antioxidant enzymes (SOD, GSH-Px) and oxidative damage markers (MDA, PCO) were measured.
- Real-time quantitative PCR (RT-qPCR): Gene expression levels of key players in the Nrf2/Keap1 pathway (CncC, Keap1, Ho-1, Gclc) were analyzed.
- Peptide sequence identification: Mass spectrometry (LC-MS/MS) was used to identify the peptide sequences within CPTP.
- Molecular docking: This computational technique was employed to predict the binding interactions between identified CPTP sequences and the Keap1 protein, specifically its Kelch domain.
Datasets
Not discussed in the paper. The study utilized commercially available reagents and a standard Drosophila melanogaster strain.
Key Insights and Ideas
- CPTP as a potent antioxidant: The in vitro results clearly demonstrate CPTP's strong ability to scavenge free radicals and enhance reducing power, suggesting it's a promising antioxidant source.
- CPTP extends lifespan without affecting appetite: The finding that CPTP extends lifespan without increasing food intake is crucial. This suggests the antiaging effect is not simply due to increased caloric intake but rather a direct biological benefit.
- Nrf2/Keap1 pathway is the key mediator: The study provides strong evidence that CPTP's antiaging effects are mediated through the activation of the Nrf2/Keap1 pathway. This is a well-established pathway for cellular defense against oxidative stress, making this a significant mechanistic insight.
- Specific peptide-Keap1 interactions: The molecular docking results are particularly interesting, as they pinpoint specific peptide sequences within CPTP that can bind to Keap1. This suggests a targeted mechanism of action, where these peptides might act as Nrf2 activators by interfering with Keap1's inhibitory function.
Key Results
- Antioxidant Activity: CPTP showed excellent in vitro antioxidant capabilities with IC50 values of 3.31 mg/ml (DPPH), 1.93 mg/ml (ABTS), and 9.52 mg/ml (hydroxyl radical).
- Lifespan Extension: A 0.8% CPTP diet significantly extended the mean and median lifespan of female flies by 7.66% and 7.85%, respectively.
- Improved Stress Resistance: CPTP treatment enhanced resistance to oxidative and heat stress, with mean lifespan extensions of 17.77% and 15.14%, respectively.
- Enhanced Antioxidant Capacity: CPTP significantly increased SOD and GSH-Px activities by 46.85% and 37.56%, respectively, while reducing MDA and PCO levels by 31.70% and 28.29% in aged flies.
- Nrf2/Keap1 Pathway Modulation: CPTP upregulated the expression of CncC (fly Nrf2 homolog) and its downstream targets Ho-1 and Gclc, while downregulating Keap1 expression.
- Peptide-Keap1 Binding: 89.23% of identified CPTP peptides showed potential inhibitory effects on Keap1, with ten representative sequences demonstrating strong binding interactions (hydrogen bonds, van der Waals, hydrophobic, and electrostatic interactions) with Keap1's active site.
Limitations and Future Work
- Starvation Stress: CPTP did not improve resistance to starvation stress, which the authors suggest might be related to triacylglyceride levels (though this was not shown).
- Maximum Lifespan: While mean and median lifespans were extended, the maximum lifespan was not significantly affected by CPTP.
- Future Work: The authors suggest that further determination of bioactive peptides with Keap1 inhibitory capability could pave the way for future peptide purification of CPTP. This implies a need for isolating and characterizing these specific antiaging peptides for more targeted applications. Investigating the effects in mammalian models would also be a logical next step.
Summary updated